Leslie’s, Inc. Announces First Quarter Fiscal 2024 Financial Results
Sales of $174.0 million Net Loss of $39.6 million Adjusted EBITDA of $(24.4) million Diluted earnings per share of $(0.21); […]
Zoom to Release Financial Results for the Fourth Quarter and Full Fiscal Year 2024
SAN JOSE, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced it will release […]
Pathfinder Bancorp, Inc. Announces Fourth Quarter 2023 Net Income of $2.5 Million and Full Year Net Income of $9.3 Million
OSWEGO, N.Y., Feb. 01, 2024 (GLOBE NEWSWIRE) — Pathfinder Bancorp, Inc. (“Company”) (NASDAQ: PBHC), the holding company for Pathfinder Bank […]
Cavco Industries Reports Fiscal 2024 Third Quarter Results and Announces New $100 Million Stock Repurchase Program
PHOENIX, Feb. 01, 2024 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) (“we,” “our,” the “Company” or “Cavco”) today announced […]
LPL Financial Announces Fourth Quarter and Full Year 2023 Results
Fourth Quarter 2023 Key Financial Results Net Income was $218 million, translating to diluted earnings per share (“EPS”) of $2.85, […]
Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results
MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth […]
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to […]
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its […]
Pool Corporation Announces Year End and Fourth Quarter 2023 Earnings Release Date and Conference Call
COVINGTON, La., Feb. 01, 2024 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq: POOL) announced today that the Company will release its full […]
Revolution Medicines to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
